Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Author Correction: Safety and immunogenicity of a tetravalent and bivalent SARS-CoV-2 protein booster vaccine in men.
Nat Commun. 2024 Jan 8;15(1):369. doi: 10.1038/s41467-024-44729-x.
Nat Commun. 2024.
PMID: 38191554
Free PMC article.
No abstract available.
Safety and immunogenicity of a tetravalent and bivalent SARS-CoV-2 protein booster vaccine in men.
Hannawi S, Saf Eldin L, Abuquta A, Alamadi A, Mahmoud SA, Hassan A, Xu S, Li J, Liu D, Baidoo AAH, Ibrahim D, Alhaj M, Chen Y, Zhou Q, Xie L.
Hannawi S, et al. Among authors: saf eldin l.
Nat Commun. 2023 Jul 8;14(1):4043. doi: 10.1038/s41467-023-39766-x.
Nat Commun. 2023.
PMID: 37422518
Free PMC article.
Item in Clipboard
Safety and immunogenicity of a bivalent SARS-CoV-2 protein booster vaccine, SCTV01C in adults previously vaccinated with inactivated vaccine: A randomized, double-blind, placebo-controlled phase 1/2 clinical trial.
Hannawi S, Saf Eldin L, Abuquta A, Alamadi A, Mahmoud SA, Li J, Chen Y, Xie L.
Hannawi S, et al. Among authors: saf eldin l.
J Infect. 2023 Feb;86(2):154-225. doi: 10.1016/j.jinf.2022.12.003. Epub 2022 Dec 9.
J Infect. 2023.
PMID: 36509358
Free PMC article.
Clinical Trial.
No abstract available.
Item in Clipboard
Cite
Cite